Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171–1187.e20 (2021).
Yao, H. et al. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 6, 76 (2020).
Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116–121 (2021).
Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 delta variant replication and immune evasion. Nature 599, 114–119 (2021).
Agerer, B. et al. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses. Sci. Immunol. 6, https://doi.org/10.1126/sciimmunol.abg6461 (2021).
Stanevich, O. V. et al. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Nat. Commun. 14, 149 (2023).
Hamelin, D. J. et al. The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner. Cell Syst. 13, 143–157 (2022).
Pretti, M. A. M., Galvani, R. G., Scherer, N. M., Farias, A. S. & Boroni, M. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8 + T cell reactivity and also signs of immune response escape. Infect. Genet. Evol. 99, 105236 (2022).
Matyášek, R. & Kovařík, A. Mutation patterns of human SARS-CoV-2 and bat RaTG13 coronavirus genomes are strongly biased towards C>U transitions, indicating rapid evolution in theirhosts. Genes 11, 761 (2020).
Simmonds, P. Rampant C→U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories. mSphere 5, e00408–e00420 (2020).
Di Giorgio, S., Martignano, F., Torcia, M. G., Mattiuz, G. & Conticello, S. G. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci. Adv. 6, eabb5813 (2020).
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
Wu, A. et al. One year of SARS-CoV-2 evolution. Cell Host Microbe 29, 503–507 (2021).
Rice, A. M. et al. Evidence for strong mutation Bias toward, and selection against, U content in SARS-CoV-2: implications for vaccine design. Mol. Biol. Evol. 38, 67–83 (2021).
Sadykov, M., Mourier, T., Guan, Q. & Pain, A. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction. J. Mol. Cell Biol. 13, 225–227 (2021).
Graudenzi, A., Maspero, D., Angaroni, F., Piazza, R. & Ramazzotti, D. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity. iScience 24, 102116 (2021).
Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360–3368 (2017).
Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells. Proc. Natl. Acad. Sci. USA. 110, E2046–E2053 (2013).
Koncz, B. et al. Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself. Proc. Natl. Acad. Sci. USA 118, e2100542118 (2021).
Bloom, J. D. & Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol. 9, vead055 (2024).
Boichard, A. et al. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. OncoImmunology 8, 1550341 (2019).
Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 (1982).
Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9, 1 (2008).
Abi-Rached, L. et al. Immune diversity sheds light on missing variation in worldwide genetic diversity panels. PLoS ONE 13, e0206512 (2018).
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
Li, Y. et al. The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification. Future Virol. 15, 341–347 (2020).
Vita, R. et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 47, D339–D343 (2019).
Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186–193 (2022).
Notarbartolo, S. et al. Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19. Sci. Immunol. 6, eabg5021 (2021).
Bergamaschi, L. et al. Longitudinal analysis reveals that delayed bystander CD8 + T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 54, 1257–1275 (2021).
Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996–1012.e19 (2020).
Bange, E. M. et al. CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat. Med. 27, 1280–1289 (2021).
Westmeier, J. et al. Impaired cytotoxic CD8 + T cell response in elderly COVID-19 patients. mBio 11, e02243–20 (2020).
Szabó, E. et al. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2. Front. Med. 10, 1176168 (2023).
Mohammed, I. et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum. Vaccin. Immunother. 18, 2027160 (2022).
Huang, C., Yang, L., Pan, J., Xu, X. & Peng, R. Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data. J. Med. Virol. 94, 2181–2187 (2022).
Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 184, 2372–2383 (2021).
Zhou, D. et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell 184, 2348–2361 (2021).
Hu, J. et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol. Immunol. 19, 293–295 (2022).
Zhang, H. et al. Profiling CD8 + T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants. Cell Rep. 36, 109708 (2021).
Kim, K. et al. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. Sci. Rep. 12, 14972 (2022).
Nakata, Y. et al. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res. 51, 783–795 (2023).
Chen, Y. et al. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antivir. Res. 149, 16–25 (2018).
Turelli, P., Mangeat, B., Jost, S., Vianin, S. & Trono, D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829–1829 (2004).
Warren, C. J. et al. APOBEC3A Functions as a restriction factor of human papillomavirus. J. Virol. 89, 688–702 (2015).
Zhu, B. et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat. Commun. 11, 886 (2020).
Cheng, A. Z. et al. APOBECs and Herpesviruses. Viruses 13, 390 (2021).
Nakaya, Y., Stavrou, S., Blouch, K., Tattersall, P. & Ross, S. R. In vivo examination of mouse APOBEC3- and human APOBEC3A- and APOBEC3G-mediated restriction of parvovirus and herpesvirus infection in mouse models. J. Virol. 90, 8005–8012 (2016).
Borzooee, F., Joris, K. D., Grant, M. D. & Larijani, M. APOBEC3G Regulation of the evolutionary race between adaptive immunity and viral immune escape is deeply imprinted in the HIV genome. Front. Immunol. 9, 3032 (2019).
Monajemi, M. et al. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8 + T Cells. PLoS ONE 9, e93428 (2014).
Kim, E.-Y. et al. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural Infection. PLoS Pathog. 10, e1004281 (2014).
Squires, K. D., Monajemi, M., Woodworth, C. F., Grant, M. D. & Larijani, M. Impact of APOBEC mutations on CD8 + T cell recognition of HIV epitopes varies depending on the restricting HLA. JAIDS J. Acquir. Immune Defic. Syndr. 70, 172–178 (2015).
Norman, J. M. et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 12, 975–983 (2011).
Bradley, C. C. et al. Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence. Nat. Microbiol. 9, 1382–1392 (2024).
Augusto, D. G. et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620, 128–136 (2023).
Le Bert, N. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 218, e20202617 (2021).
Oran, D. P. & Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann. Intern. Med. 173, 362–367 (2020).
Johansson, M. A. et al. SARS-CoV-2 Transmission from people without COVID-19 symptoms. JAMA Netw. Open 4, e2035057 (2021).
Tan, J. et al. Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study. Epidemiol. Infect. 150, e171 (2022).
Emery, J. C. et al. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. ELife 9, e58699 (2020).
van Dorp, L. et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect. Genet. Evol. 83, 104351 (2020).
Directional mutational pressure affects the amino acid composition and hydrophobicity of proteins in bacteria. in Contemporary Issues in Genetics and Evolution 383–391 (Springer Netherlands, Dordrecht, 1998).
Simmonds, P. & Ansari, M. A. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PLoS Pathog. 17, e1009596 (2021).
Geoghegan, J. L., Duchêne, S. & Holmes, E. C. Comparative analysis estimates the relative frequencies of co-divergence and cross-species transmission within viral families. PLoS Pathog. 13, e1006215 (2017).
Woolhouse, M. E. J. Population biology of emerging and re-emerging pathogens. Trends Microbiol. 10, s3–s7 (2002).
Kreuder Johnson, C. et al. Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci. Rep. 5, 14830 (2015).
Enard, D. & Petrov, D. A. Ancient RNA virus epidemics through the lens of recent adaptation in human genomes. Philos. Trans. R. Soc. B 375, 20190575 (2020).
Huang, L., Kuhls, M. C. & Eisenlohr, L. C. Hydrophobicity as a driver of MHC class I antigen processing: Hydrophobicity in MHC class I peptide supply. EMBO J. 30, 1634–1644 (2011).
Chen, H. et al. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer. Cancer Sci. 110, 2348–2356 (2019).
Driscoll, C. B. et al. APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nat. Commun. 11, 790 (2020).
DiMarco, A. V. et al. APOBEC Mutagenesis inhibits breast cancer growth through induction of T cell–mediated antitumor immune Responses. Cancer Immunol. Res. 10, 70–86 (2022).
Mullane, S. A. et al. Correlation of Apobec Mrna expression with overall survival and pd-l1 expression in urothelial carcinoma. Sci. Rep. 6, 27702 (2016).
Smid, M. et al. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nat. Commun. 7, 12910 (2016).
Wang, S., Jia, M., He, Z. & Liu, X.-S. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer. Oncogene 37, 3924–3936 (2018).
Conticello, S. G. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229 (2008).
O’Leary, M. A. et al. The placental mammal ancestor and the post–K-Pg radiation of placentals. Science 339, 662–667 (2013).
Gong, S., Xie, H. & Chen, F. Spatiotemporal changes of epidemics and their relationship with human living environments in China over the past 2200 years. Sci. China Earth Sci. 63, 1223–1226 (2020).
Morabia, A. Epidemic and population patterns in the Chinese Empire (243 b.c.e. to 1911 c.e.): quantitative analysis of a unique but neglected epidemic catalogue. Epidemiol. Infect. 137, 1361–1368 (2009).
Souilmi, Y. et al. An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Curr. Biol. 31, 3504–3514 (2021).
Morris, S. C. et al. Natural selection exerted by historical coronavirus epidemic(s): comparative genetic analysis in China Kadoorie Biobank and UK Biobank. Preprint at https://doi.org/10.1101/2024.02.06.579075 (2024).
Ihaka, R. & Gentleman, R. R: A language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299–314 (1996).
Wickham, H. ggplot2. WIREs Comput. Stats 3, 180–185 (2011).
Kassambara, A. Ggpubr: ‘ggplot2’ Based Publication Ready Plots. (2025).
Gordon, M. & Lumley, T. Forestplot: Advanced Forest Plot Using ‘grid’ Graphics. (2025).
Kolde, R. Pheatmap: Pretty Heatmaps. (2025).
Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).
Wilke, C. O. Cowplot: Streamlined Plot Theme and Plot Annotations for ‘Ggplot2’. (2025).
Ogle, D. H., Doll, J. C., Wheeler, A. P. & Dinno, A. FSA: simple fisheries stock assessment methods. https://doi.org/10.32614/CRAN.package.FSA (2015).
Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmertest package: tests in linear mixed effects models. J. Stat. Soft. 82, 1–26 (2017).
Solt, F. & Hu, Y. Dotwhisker: Dot-and-Whisker Plots of Regression Results. (2024).
Bolker, B. & Robinson, D. broom.mixed: Tidying methods for mixed models. https://doi.org/10.32614/CRAN.package.broom.mixed (2018).
Kassambara, A. rstatix: Pipe-friendly framework for basic statistical tests. https://doi.org/10.32614/CRAN.package.rstatix (2019).
Pohlert, T. PMCMRplus: Calculate pairwise multiple comparisons ofmean rank sums extended. https://doi.org/10.32614/CRAN.package.PMCMRplus (2018).
Klimczak, L. J., Randall, T. A., Saini, N., Li, J.-L. & Gordenin, D. A. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic. PLoS ONE 15, e0237689 (2020).
Marty, R. et al. MHC-I Genotype restricts the oncogenic mutational landscape. Cell 171, 1272–1283 (2017).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289–300 (1995).
Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199–209 (2020).
Tremblay, B. J.-M. universalmotif: An R package for biological motifanalysis. JOSS 9, 7012 (2024).
Brown, D. W., Myers, T. A. & Machiela, M. J. PCAmatchR: a flexible R package for optimal case–control matching using weighted principal components. Bioinformatics 37, 1178–1181 (2021).
van Dorp, L. et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat. Commun. 11, 1–8 (2020).
Honfi, D. et al. Comparison of homologous and heterologous booster SARS-CoV-2 vaccination in autoimmune rheumatic and musculoskeletal patients. IJMS 23, 11411 (2022).
Szebeni, G. J. et al. Humoral and cellular immunogenicity and safety of five different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases in remission or with low disease activity and in healthy controls: a single center study. Front. Immunol. 13, 846248 (2022).
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
Elliott, J. et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur. J. Epidemiol. 36, 299–309 (2021).
Rowlands, A. V. et al. Association between accelerometer-assessed physical activity and severity of COVID-19 in UK Biobank. Mayo Clin. Proc. Innov. Qual. Outcomes 5, 997–1007 (2021).
Mathieu, E. et al. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 5, 947–953 (2021).
Dobrijević, Z. et al. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis. Rev. Med. Virol. 33, e2378 (2023).
Balogh, G. et al. C > U mutations generate immunogenic peptides in SARS-CoV-2. Zenodo https://doi.org/10.5281/ZENODO.17019282 (2025).
